LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition (Q43188970)
Jump to navigation
Jump to search
scientific article published in January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition |
scientific article published in January 2009 |
Statements
1 reference
LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition (English)
1 reference
P A Futreal
1 reference
M R Stratton
1 reference
H Davies
1 reference
C L Mahoney
1 reference
S Edkins
1 reference
C Greenman
1 reference
G van Haaften
1 reference
T Mironenko
1 reference
T Santarius
1 reference
C Stevens
1 reference
1 reference
Identifiers
1 reference